RecruitingNot applicableNCT06474520

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

Studying Acute disseminated encephalomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tongji Hospital
Principal Investigator
Wei Wang, MD
Tongji Hospital
Intervention
Calculus bovis sativus (CBS)(drug)
Enrollment
250 enrolled
Eligibility
18 years · All sexes
Timeline
20242029

Study locations (1)

Collaborators

Jianmin Pharmaceutical Group Co., LTD.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06474520 on ClinicalTrials.gov

Other trials for Acute disseminated encephalomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Acute disseminated encephalomyelitis

← Back to all trials